PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting

被引:83
作者
Monsalve, Yuliana [1 ]
Tosi, Giovanni [2 ]
Ruozi, Barbara [2 ]
Belletti, Daniela [2 ]
Vilella, Antonietta [3 ]
Zoli, Michele [3 ]
Vandelli, Maria Angela [2 ]
Forni, Flavio [2 ]
Lopez, Betty L. [1 ]
Sierra, Ligia [1 ]
机构
[1] Univ Antioquia, Grp Invest Ciencia Mat, Inst Quim, Fac Ciencias Exactas & Nat, Medellin, Colombia
[2] Univ Modena & Reggio Emilia, Dept Life Sci, Pharmaceut Technol, Te Far TI Grp, I-41124 Modena, Italy
[3] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, I-41124 Modena, Italy
关键词
blood-brain barrier; chitosan; drug targeting; monoclonal antibody OX26; nanoparticles; POLYMERIC NANOPARTICLES; BARRIER DISRUPTION; DELIVERY; BIODISTRIBUTION; TRANSPORT; INSIGHT; CROSS; FATE;
D O I
10.2217/nnm.15.29
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
Aim: Drug targeting to the CNS is challenging due to the presence of blood-brain barrier. We investigated chitosan (Cs) nanoparticles (NPs) as drug transporter system across the blood-brain barrier, based on mAb OX26 modified Cs. Materials & methods: Cs NPs functionalized with PEG, modified and unmodified with OX26 (Cs-PEG-OX26) were prepared and chemico-physically characterized. These NPs were administered (intraperitoneal) in mice to define their ability to reach the brain. Results: Brain uptake of OX26-conjugated NPs is much higher than of unmodified NPs, because: long-circulating abilities (conferred by PEG), interaction between cationic Cs and brain endothelium negative charges and OX26 TfR receptor affinity. Conclusion: Cs-PEG-OX26 NPs are promising drug delivery system to the CNS.
引用
收藏
页码:1735 / 1750
页数:16
相关论文
共 56 条
[1]
Enhanced Antitumor Activity of the Photosensitizer meso-Tetra(N-methyl-4-pyridyl) Porphine Tetra Tosylate through Encapsulation in Antibody-Targeted Chitosan/Alginate Nanoparticles [J].
Abdelghany, Sharif M. ;
Schmid, Daniela ;
Deacon, Jill ;
Jaworski, Jakub ;
Fay, Francois ;
McLaughlin, Kirsty M. ;
Gormley, Julie A. ;
Burrows, James F. ;
Longley, Daniel B. ;
Donnelly, Ryan F. ;
Scott, Christopher J. .
BIOMACROMOLECULES, 2013, 14 (02) :302-310
[2]
Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26 [J].
Aktas, Y ;
Yemisci, M ;
Andrieux, K ;
Gürsoy, RN ;
Alonso, MJ ;
Fernandez-Megia, E ;
Novoa-Carballal, R ;
Quiñoá, E ;
Riguera, R ;
Sargon, MF ;
Çelik, HH ;
Demir, AS ;
Hincal, AA ;
Dalkara, T ;
Çapan, Y ;
Couvreur, P .
BIOCONJUGATE CHEMISTRY, 2005, 16 (06) :1503-1511
[3]
[Anonymous], PHARM SINICA
[4]
Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system [J].
Aryal, Muna ;
Arvanitis, Costas D. ;
Alexander, Phillip M. ;
McDannold, Nathan .
ADVANCED DRUG DELIVERY REVIEWS, 2014, 72 :94-109
[5]
AZIZ HA, 2013, INT C IND ENG MAN SC, P936
[6]
Chitosan particle/multiwall carbon nanotube composites by electrostatic interactions [J].
Baek, Seung-Hoon ;
Kim, Bumsu ;
Suh, Kyung-Do .
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2008, 316 (1-3) :292-296
[7]
Influence of cetyltrimethylammonium bromide on physicochemical properties and microstructures of chitosan-TPP nanoparticles in aqueous solutions [J].
Bao, Hongqian ;
Li, Lin ;
Zhang, Hongbin .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2008, 328 (02) :270-277
[8]
Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: A technical note [J].
Bhumkar, Devika R. ;
Pokharkar, Varsha B. .
AAPS PHARMSCITECH, 2006, 7 (02)
[9]
Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO
[10]
2-4